 |
| |||
| воспроизведённые препараты (только в отношении биологических препаратов baloff) | |||
| |||
| биоподобный лекарственный препарат (Biosimilars or follow-on biologics are terms used to describe officially-approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product.[1] Biosimilars are also referred to as subsequent entry biologics (SEBs) in Canada (WAD) Alexander Demidov); биоподобный препарат (Alexander Demidov) | |||
| биоаналог (roszdravnadzor.ru Baxter); биопрепарат (Marina Hert); биоэквивалентное лекарственное средство (Marina Hert) | |||
| biosimilars: 6 phrases in 3 subjects |
| Biochemistry | 1 |
| Medical | 2 |
| Pharmacology | 3 |